Illumina, Applied Biosystems, Tranzyme, Neokimia, Tm Bioscience, Calgary Labs, Procter & Gamble, Sequenom, Genaissance, GE, Bristol-Myers, Exelixis, Lexicon, AstraZeneca | GenomeWeb

Don’t Make Me Pull the Car Over. ABI- Illumina Dispute Heads for Arbitration

A California judge ordered Illumina and Applied Biosystems to take their breach-of-contract dispute to an arbitrator, Illumina said late last week.

The legal tussle arises out of an agreement the companies penned in 1999 to jointly commercialize a genotyping system. In July 2002, following delays in the development of the system, Illumina decided to launch its own platform, the BeadArray SNP genotyping system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.